A pharmaceutical product having excellent adiponectin production ability, and food useful for the pharmaceutical product is provided. The pharmaceutical product contains, as active ingredients, a sugar having a polymerization degree of 2-10, wherein mannose units account for not less than 50% based on the number, and a chlorogenic acid.